|
pedicel mucilage metabolic process
|
GO_0048362 |
[The chemical reactions and pathways involving mucilage that occur in the flower stem.] |
|
pectin metabolic process
|
GO_0045488 |
[The chemical reactions and pathways involving pectin, a group of galacturonic acid-containing, water-soluble colloidal carbohydrates of high molecular weight and of net negative charge.] |
|
insulin catabolic process
|
GO_1901143 |
[The chemical reactions and pathways resulting in the breakdown of insulin.] |
|
obsolete insulin biosynthetic process
|
GO_1901144 |
[OBSOLETE. The chemical reactions and pathways resulting in the formation of insulin.] |
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO_1901145 |
[Any mesenchymal cell apoptotic process that is involved in nephron morphogenesis.] |
|
mesenchymal cell apoptotic process
|
GO_0097152 |
[Any apoptotic process in a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.] |
|
mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis
|
GO_1901146 |
[Any mesenchymal cell apoptotic process that is involved in mesonephric nephron morphogenesis.] |
|
mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis
|
GO_1901147 |
[Any mesenchymal cell apoptotic process that is involved in metanephric nephron morphogenesis.] |
|
mesenchymal cell apoptotic process involved in metanephros development
|
GO_1900200 |
[Any mesenchymal cell apoptotic process that is involved in metanephros development.] |
|
gene expression involved in extracellular matrix organization
|
GO_1901148 |
[Any gene expression that is involved in extracellular matrix organization. Gene expression includes both transcription to produce an RNA transcript, and the translation of that mRNA into protein. Protein maturation is included in gene expression when required to form an active form of a product from an inactive precursor form.] |
|
salicylic acid binding
|
GO_1901149 |
[Binding to salicylic acid.] |
|
intermediate mesodermal cell fate commitment
|
GO_0048393 |
[The process in which the developmental fate of a cell becomes restricted such that it will develop into an intermediate mesoderm cell.] |
|
intermediate mesodermal cell fate determination
|
GO_0048394 |
[The process in which a cell becomes capable of differentiating autonomously into a intermediate mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.] |
|
intermediate mesoderm formation
|
GO_0048391 |
[The process that gives rise to the intermediate mesoderm. This process pertains to the initial formation of the structure from unspecified parts.] |
|
intermediate mesodermal cell differentiation
|
GO_0048392 |
[The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.] |
|
positive regulation of intermediate mesodermal cell fate determination
|
GO_0048397 |
[Any process that activates or increases the frequency, rate or extent of intermediate mesoderm cell fate determination.] |
|
regulation of intermediate mesodermal cell fate determination
|
GO_0048395 |
[Any process that modulates the frequency, rate or extent of intermediate mesoderm cell fate determination.] |
|
vistamycin metabolic process
|
GO_1901150 |
[The chemical reactions and pathways involving vistamycin.] |
|
intermediate mesodermal cell fate specification
|
GO_0048398 |
[The process in which a cell becomes capable of differentiating autonomously into an intermediate mesoderm cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed.] |
|
vistamycin catabolic process
|
GO_1901151 |
[The chemical reactions and pathways resulting in the breakdown of vistamycin.] |